Katarzyna Mleczko-Sanecka

Dr. Katarzyna Mleczko-Sanecka


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2009 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
GCGuillem Casanovas
Guillem Casanovas
KMKatarzyna Mleczko-Sanecka
Katarzyna Mleczko-Sanecka
SASandro Altamura
Sandro Altamura
MHMatthias W. Hentze
Matthias W. Hentze
MMMartina Ulrike Muckenthaler
Martina Ulrike Muckenthaler

5 March 2014 in Gut
Verified
Journal Article
Open access
PDF file
TSThomas Sonnweber
Thomas Sonnweber
DNDavid Nachbaur
David Nachbaur
ASAndrea Schroll
Andrea Schroll
MNManfred Nairz
Manfred Nairz
MSMarkus Seifert
Markus Seifert
GWGünter Weiss
Günter Weiss
Objective Hypoxia affects body iron homeostasis; however, the underlying mechanisms are incompletely understood. Design Using a standardised hypoxia chamber, 23 healthy volunteers were subjected to hypoxic conditions, equivalent to an altitude of 5600 m, for 6 h. Subsequent experiments were performed in C57BL/6 mice, CREB-H knockout mice, primary hepatocytes and HepG2 cells. Results Exposure of subjects to hypoxia resulted in a significant decrease of serum levels of the master regulator of iron homeostasis hepcidin and elevated concentrations of platelet derived growth factor (PDGF)-BB. Using correlation analysis, we identified PDGF-BB to be associated with hypoxia mediated hepcidin repression in humans. We then exposed mice to hypoxia using a standardised chamber and observed downregulation of hepatic hepcidin mRNA expression that was paralleled by elevated serum PDGF-BB protein concentrations and higher serum iron levels as compared with mice housed under normoxic conditions. PDGF-BB treatment in vitro and in vivo resulted in suppression of both steady state and BMP6 inducible hepcidin expression. Mechanistically, PDGF-BB inhibits hepcidin transcription by downregulating the protein expression of the transcription factors CREB and CREB-H, and pharmacological blockade or genetic ablation of these pathways abrogated the effects of PDGF-BB toward hepcidin expression. Conclusions Hypoxia decreases hepatic hepcidin expression by a novel regulatory pathway exerted via PDGF-BB, leading to increased availability of circulating iron that can be used for erythropoiesis.

1 April 2010 in Blood
Verified
Journal Article
Closed access
KMKatarzyna Mleczko-Sanecka
Katarzyna Mleczko-Sanecka
GCGuillem Casanovas
Guillem Casanovas
ARAnan Ragab
Anan Ragab
KBKatja Breitkopf
Katja Breitkopf
AMAlexandra Müller
Alexandra Müller
MMMartina Ulrike Muckenthaler
Martina Ulrike Muckenthaler
Hepcidin is the master regulatory hormone of systemic iron metabolism. Hepcidin deficiency causes common iron overload syndromes whereas its overexpression is responsible for microcytic anemias. Hepcidin transcription is activated by the bone morphogenetic protein (BMP) and the inflammatory JAK-STAT pathways, whereas comparatively little is known about how hepcidin expression is inhibited. By using high-throughput siRNA screening we identified SMAD7 as a potent hepcidin suppressor. SMAD7 is an inhibitory SMAD protein that mediates a negative feedback loop to both transforming growth factor-β and BMP signaling and that recently was shown to be coregulated with hepcidin via SMAD4 in response to altered iron availability in vivo. We show that SMAD7 is coregulated with hepcidin by BMPs in primary murine hepatocytes and that SMAD7 overexpression completely abolishes hepcidin activation by BMPs and transforming growth factor-β. We identify a distinct SMAD regulatory motif (GTCAAGAC) within the hepcidin promoter involved in SMAD7-dependent hepcidin suppression, demonstrating that SMAD7 does not simply antagonize the previously reported hemojuvelin/BMP-responsive elements. This work identifies a potent inhibitory factor for hepcidin expression and uncovers a negative feedback pathway for hepcidin regulation, providing insight into a mechanism how hepcidin expression may be limited to avoid iron deficiency.

30 August 2021 in Genes
Verified
Journal Article
Open access
PDF file
PSPatryk Slusarczyk
Patryk Slusarczyk
KMKatarzyna Mleczko-Sanecka
Katarzyna Mleczko-Sanecka
The production of around 2.5 million red blood cells (RBCs) per second in erythropoiesis is one of the most intense activities in the body. It continuously consumes large amounts of iron, approximately 80% of which is recycled from aged erythrocytes. Therefore, similar to the “making”, the “breaking” of red blood cells is also very rapid and represents one of the key processes in mammalian physiology. Under steady-state conditions, this important task is accomplished by specialized macrophages, mostly liver Kupffer cells (KCs) and splenic red pulp macrophages (RPMs). It relies to a large extent on the engulfment of red blood cells via so-called erythrophagocytosis. Surprisingly, we still understand little about the mechanistic details of the removal and processing of red blood cells by these specialized macrophages. We have only started to uncover the signaling pathways that imprint their identity, control their functions and enable their plasticity. Recent findings also identify other myeloid cell types capable of red blood cell removal and establish reciprocal cross-talk between the intensity of erythrophagocytosis and other cellular activities. Here, we aimed to review the multiple and emerging facets of iron recycling to illustrate how this exciting field of study is currently expanding.

6 March 2014 in Blood
Verified
Journal Article
Open access
PDF file
KMKatarzyna Mleczko-Sanecka
Katarzyna Mleczko-Sanecka
FRFranziska Roche
Franziska Roche
ASAna Rita da Silva
Ana Rita da Silva
DCDebora Call
Debora Call
FDFlavia D’aLessio
Flavia D’aLessio
MMMartina Ulrike Muckenthaler
Martina Ulrike Muckenthaler
Key Points: Genome-wide RNAi screen provides the first comprehensive list of putative hepatic hepcidin regulators. Hepcidin suppression is linked to the control of mitogen stimulation and nutrient status via components of Ras/RAF MAPK and mTOR signaling.

17 September 2020 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
KMKatarzyna Mleczko-Sanecka
Katarzyna Mleczko-Sanecka
LSLaura Silvestri
Laura Silvestri